• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ranibizumab for age-related macular degeneration.

作者信息

Cheng Jin-Wei, Wei Rui-Li

出版信息

N Engl J Med. 2011 Feb 10;364(6):582. doi: 10.1056/NEJMc1013316.

DOI:10.1056/NEJMc1013316
PMID:21306263
Abstract
摘要

相似文献

1
Ranibizumab for age-related macular degeneration.雷珠单抗用于年龄相关性黄斑变性
N Engl J Med. 2011 Feb 10;364(6):582. doi: 10.1056/NEJMc1013316.
2
Ranibizumab for age-related macular degeneration.雷珠单抗用于治疗年龄相关性黄斑变性。
N Engl J Med. 2011 Feb 10;364(6):581-2. doi: 10.1056/NEJMc1013316.
3
Ranibizumab therapy for neovascular age-related macular degeneration.雷珠单抗治疗新生血管性年龄相关性黄斑变性
N Engl J Med. 2010 Oct 21;363(17):1648-55. doi: 10.1056/NEJMct1000495.
4
Randomized study of bevacizumab vs ranibizumab for age-related macular degeneration: inappropriate conclusions.贝伐单抗与雷珠单抗治疗年龄相关性黄斑变性的随机研究：不恰当的结论。
Am J Ophthalmol. 2010 May;149(5):867; author reply 867. doi: 10.1016/j.ajo.2009.12.039.
5
Ocular and systemic safety of bevacizumab and ranibizumab in patients with neovascular age-related macular degeneration.贝伐单抗和雷珠单抗治疗新生血管性年龄相关性黄斑变性的眼部和全身安全性。
Curr Opin Ophthalmol. 2013 May;24(3):205-12. doi: 10.1097/ICU.0b013e32835f8ec0.
6
Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial.贝伐单抗与雷珠单抗治疗年龄相关性黄斑变性：一项前瞻性双盲随机临床试验的早期结果
Am J Ophthalmol. 2010 Aug;150(2):287; author reply 287. doi: 10.1016/j.ajo.2010.04.006.
7
[Non-response and change of anti-VEGF agent in exsudative age-related macular degeneration].
Klin Monbl Augenheilkd. 2010 Aug;227(8):657-8. doi: 10.1055/s-0029-1245165. Epub 2010 Aug 12.
8
Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial.贝伐单抗与雷珠单抗治疗年龄相关性黄斑变性：一项前瞻性双盲随机临床试验的早期结果
Am J Ophthalmol. 2009 Dec;148(6):875-82.e1. doi: 10.1016/j.ajo.2009.07.009. Epub 2009 Oct 2.
9
Lessons learnt inform our approach to new antivascular endothelial growth factor treatments for neovascular age-related macular degeneration.所汲取的经验教训为我们采用新的抗血管内皮生长因子疗法治疗新生血管性年龄相关性黄斑变性提供了指导。
Clin Exp Ophthalmol. 2013 Nov;41(8):723-6. doi: 10.1111/ceo.12212.
10
The effect of image quality on retinal nerve fiber layer measurement in Stratus OCT.
Am J Ophthalmol. 2011 Feb;151(2):384; author reply 384-5. doi: 10.1016/j.ajo.2010.10.012.

引用本文的文献

1
A Large Outbreak of Fulminant Bacterial Endophthalmitis after Intravitreal Injection of Counterfeit Bevacizumab.玻璃体内注射假冒贝伐单抗后暴发性细菌性眼内炎的大规模暴发
Graefes Arch Clin Exp Ophthalmol. 2016 Sep;254(9):1851-6. doi: 10.1007/s00417-016-3426-7. Epub 2016 Jul 4.
2
Intravitreal administration of bevacizumab: pros and cons.玻璃体腔内注射贝伐单抗：利弊
Daru. 2015 Apr 21;23(1):27. doi: 10.1186/s40199-015-0110-0.
3
Growth of Scytalidium sp. in a counterfeit bevacizumab bottle.斯克里达尔氏菌在假冒贝伐珠单抗瓶中的生长。
Indian J Ophthalmol. 2013 Sep;61(9):523-5. doi: 10.4103/0301-4738.119455.
4
An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.玻璃体内注射贝伐单抗后发生内源性链球菌眼内炎。
Am J Ophthalmol. 2012 Feb;153(2):204-208.e1. doi: 10.1016/j.ajo.2011.11.035.
5
Lasting controversy on ranibizumab and bevacizumab.雷珠单抗和贝伐单抗的持久争议。
Theranostics. 2011;1:395-402. doi: 10.7150/thno/v01p0395. Epub 2011 Dec 12.